fetching data ...

AB0012 (2026)
IMPACT OF HLA EVOLUTIONARY DIVERGENCE ON PEPTIDE PRESENTATION AND PATHOGEN MIMICRY IN THE PATHOGENESIS OF SLE
Keywords: -omics, Adaptive immunity, Autoimmunity
R. Domínguez Rodríguez1, E. Carnero-Montoro1,2, P. Cytometry Consortium1, R. Díaz Peña3,4, M. Alarcon-Riquelme1,5, G. Barturen1,2,6
1Center for Genomics and Oncological Research (GENyO), Pfizer/University of Granada/Andalusian Government, Granada, Spain
2University of Granada, Granada, Spain
3Immunogenetics Lab, Fundación Pública Galega de Medicina Xenómica, SERGAS, Grupo de Medicina Xenómica-USC, Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain
4Faculty of Health Sciences, Universidad Autónoma de Chile, Talca, Chile
5Institute for Environmental Medicine, Karolinska Institute, Stockholm, Sweden
6Bioinformatics Laboratory, Biotechnology Institute, Centro de Investigación Biomédica, Granada, Spain

Background: Genetic variation within the human leukocyte antigen (HLA) region influences susceptibility across systemic autoimmune diseases (SADs). HLA evolutionary divergence (HED) may influence the breadth of antigen presentation, while pathogen-driven molecular mimicry could contribute to disease heterogeneity.


Objectives: To evaluate HLA class I and II alleles, their evolutionary divergence, and peptide-binding profiles in SLE compared to other systemic autoimmune diseases (SADs), focusing on potential pathogen-driven autoimmunity and clinical relevance.


Methods: HLA class I/II genotypes were analyzed from three SLE cohorts (GWASEUR, n=6,919; SLEGEN, n=3,806; PRECISESADS SLE, n=357) and other SADs (SjS 353, SSc 337, RA 315, UCTD 154, PAPS 89, MCTD 75, controls 486) under an additive model. HED was calculated using the Grantham-based Pierini & Lenz algorithm. Predicted immunopeptidomes for HLA-DQA1-DQB1 and HLA-DRB1 were analyzed with NetMHCIIpan 4.2, and viral, bacterial, and archaeal peptide homology was assessed using blastp (≥80% sequence identity).


Results: DRB1*03:01 (DR3 haplotype) and DRB1*15:01–DQB1*06:02 (DR2 haplotype) were confirmed as independent SLE risk alleles, while DRB1*04:01 predominated in RA. SLE patients exhibited significantly higher DQB1 divergence (p<10 −5 ), consistent with broader predicted peptide presentation, whereas DRB1 divergence was modestly reduced in SjS and other SADs. HED correlated with predicted peptide-binding repertoire size (DQB1 ρ=0.65; DRB1 ρ=0.62). Heterozygotes for DR2-DR3 showed the highest DQB1 divergence. Importantly, DRB1*03:01 and DRB1*15:01 alleles presented a relatively small total peptide repertoire but a high number of allele-specific peptides exhibiting homology to viral, bacterial, and archaeal proteins, compared to other alleles, suggesting a potential mechanism of pathogen-driven autoimmunity. By contrast, DQA1-DQB1 alleles in the risk haplotypes lacked enrichment of allele-specific peptides homologous to viral, bacterial, or archaeal proteins, emphasizing the allele-specific role of DRB1 in shaping immune recognition and SLE susceptibility.


Conclusions: HLA evolutionary divergence shapes antigen presentation and may contribute to SLE susceptibility. DRB1*03:01 and DRB1*15:01 appear to promote autoimmunity through recognition of peptides homologous to pathogens, whereas DQB1 alleles in the same haplotypes do not show this pattern.


REFERENCES: NIL.


Acknowledgments: NIL.


Disclosure of Interests: None declared.


DOI: annrheumdis-2026-eular.A.1090
Keywords: -omics, Adaptive immunity, Autoimmunity
Citation: , volume 85, supplement 1, year 2026, page s1390
Session: Basic and Translational - Across diseases (Publication Only)